potassium bitartrate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4694	868-14-4

Description:

Molecule

Description

Synonyms:

potassium hydrogentartrate
monopotassium tartrate
potassium hydrogen tartrate
potassium hydrotartrate
potassium bitartrate

Molecular weight: 188.18
Formula: C4H5KO6
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 117.89
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
7.50	g	O

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Drug abuse	35.59	31.74	15	459	72503	63416045

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Drug abuse	44.81	27.73	24	698	162667	79580999
Cardio-respiratory arrest	32.63	27.73	17	705	108493	79635173
Toxicity to various agents	30.02	27.73	27	695	421513	79322153

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A12BA03	ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS POTASSIUM Potassium
CHEBI has role	CHEBI:33281	antibiotics
CHEBI has role	CHEBI:50503	laxante
CHEBI has role	CHEBI:64049	pH control agents
CHEBI has role	CHEBI:76924	plant metabolites
CHEBI has role	CHEBI:77965	food anti-caking agent
CHEBI has role	CHEBI:77966	food stabilisers
CHEBI has role	CHEBI:77969	food humectants
CHEBI has role	CHEBI:77971	food raising agent

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Patent number	Patent expiration date	Patent use
1%;1.8%;0.4%	PHEXXI	EVOFEM INC	N208352	May 22, 2020	RX	GEL	VAGINAL	10568855	March 15, 2033	PREVENTION OF PREGNANCY
1%;1.8%;0.4%	PHEXXI	EVOFEM INC	N208352	May 22, 2020	RX	GEL	VAGINAL	11337989	March 15, 2033	PREVENTION OF PREGNANCY

Orange Book exclusivity data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
1%;1.8%;0.4%	PHEXXI	EVOFEM INC	N208352	May 22, 2020	RX	GEL	VAGINAL	May 22, 2023	NEW PRODUCT

Bioactivity Summary:

None

External reference:

ID	Source
D01561	KEGG_DRUG
4019250	VUID
N0000147455	NUI
4019250	VANDF
CHEBI:32034	CHEBI
CHEMBL2105248	ChEMBL_ID
DB11107	DRUGBANK_ID
223779	RXNORM
21417	MMSL
NOCODE	MMSL
d05810	MMSL
001199	NDDF
116529007	SNOMEDCT_US
421836004	SNOMEDCT_US
C0727538	UMLSCUI
CHEMBL2028510	ChEMBL_ID
23681127	PUBCHEM_CID
NPT6P8P3UU	UNII

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
CEO-TWO	HUMAN OTC DRUG LABEL	2	0283-0808	SUPPOSITORY	927 mg	RECTAL	OTC monograph not final	15 sections
CEO-TWO	HUMAN OTC DRUG LABEL	2	0283-0808	SUPPOSITORY	927 mg	RECTAL	OTC monograph not final	15 sections
Phexxi	HUMAN PRESCRIPTION DRUG LABEL	3	69751-100	GEL	20 mg	VAGINAL	NDA	25 sections